e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Tobacco smoking related health issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adverse reactions to bupropion: fourteen cases reported in a French regional pharmacovigilance center. Impact on smoking withdrawal
C. Andrejak, M. Andrejak, P. Aubry, V. Jounieaux (Amiens, France)
Source:
Annual Congress 2005 - Tobacco smoking related health issues
Session:
Tobacco smoking related health issues
Session type:
Thematic Poster Session
Number:
1022
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Andrejak, M. Andrejak, P. Aubry, V. Jounieaux (Amiens, France). Adverse reactions to bupropion: fourteen cases reported in a French regional pharmacovigilance center. Impact on smoking withdrawal. Eur Respir J 2005; 26: Suppl. 49, 1022
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical phenotypes of severe asthma: adults
A 55-year-old woman with sided dull aching chest pain
Results of Turkish smoking cessation polyclinics data’s analysis (TUSPA study)
Related content which might interest you:
Adverse drug reactions in a pulmonary teaching hospital: Incidence, pattern, seriousness, and preventability
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011
Management of adverse drug events in TB therapy
Source: Eur Respir Mon 2012; 58: 167-193
Year: 2012
Alcohol intake, smoking and illicit drug use in TB patients is under recorded by doctors
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Adverse effects of MDR-TB treatment with a standardized regimen: A report from Iran
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β
2
-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009
Smoking cessation for free: First long-term outcomes in three Romanian centres
Source: International Congress 2015 – Smoking cessation
Year: 2015
Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations)
Source: Eur Respir J 2007; 30: Suppl. 51, 125s
Year: 2007
Adverse anti-tuberculosis drug events and their management
Source: Eur Respir Monogr 2018; 82: 205-227
Year: 2018
Putting in Harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for Multidrug-Resistant Tuberculosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Efficacy of varenicline among smokers enrolled on a public health tobacco control program (HM-TCP) in the real-life setting
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Late-breaking abstract: Long-term efficacy of intensive behavior interventions and free medications for smoking cessation in Brazil
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011
Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005
Prevalence of switching from brand to generic asthma medications
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Evaluation of rate and associated factors with relapse in patients attending smoking cessation programme
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Occupational exposure and incidence of asthma based on prescription of drugs.
Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways
Year: 2018
Smoke cessation recommendations and prescriptions in hospitalised medical patients
Source: International Congress 2015 – Smoking cessation
Year: 2015
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Adverse pregnancy outcomes and familial confounding in asthmatic women – A population based family design study
Source: International Congress 2016 – Predictors of asthma among children and adults
Year: 2016
Metrics of salbutamol use as predictors of future adverse outcomes in asthma
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept